共 2 条
[1]
[2]
The orally active nonpeptide selective endothelin ET A receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats[J] Hironori Yuyama;Akira Fujimori;Masanao Sanagi;Akiko Koakutsu;Katsumi Sudoh;Masao Sasamata;Keiji Miyata European Journal of Pharmacology 2004,

